TIDMSUN
Surgical Innovations Group PLC
09 February 2021
Surgical Innovations Group plc
("Surgical Innovations", "SI" or the "Company")
Launch of the Green Surgery Challenge
Event sponsor to promote the use of sustainable products in
surgery
Surgical Innovations Group plc (AIM: SUN), the designer,
manufacturer and distributor of innovative medical technology for
minimally invasive surgery ("MIS"), announces that Elemental
Healthcare Limited, a wholly owned SI subsidiary, was a key sponsor
at the launch of the Green Surgery Challenge 2021*, which took
place last week.
This competition , initiated by Elemental Healthcare and
developed by the Centre for Sustainable Healthcare ("CSH"), allows
UK operating theatres to present innovative ideas to reduce their
Carbon Footprint. The national competition has been organised by
the CSH, Royal College of Surgeons England, Royal College of
Surgeons of Scotland and NIHR Surgical Med Tech Co-op and is
endorsed by a number of significant charities and official
bodies.
The Green Surgery Challenge 2021 is an opportunity for the UK's
surgical community to recognise the value of sustainable healthcare
for surgical conditions, share and promote ways of practicing that
are less harmful to the environment and the planet and build social
sustainability, transforming surgery for the future. The launch
event attracted over 400 delegates.
The recording can be accessed here:
https://youtu.be/Nb2EimC2-0c
As announced in November 2020, SI has an ongoing collaboration
with the CSH, enabling the Company to validate the environmental
messaging for SI's products and demonstrate the quantifiable
benefits in cost and environmental savings from a 'greener'
operating room, with particular focus on reducing plastic waste in
surgery in the UK and globally.
Adam Power, SI Group Development Director, commented: "We are
pleased to be part of the Green Surgery Challenge launch, bringing
sustainability to the forefront of hospital agendas. We are one of
the only significant players in the space with our Resposable (TM)
product portfolio and are passionate to lead and support innovative
ideas to reduce public sector waste and emissions, much of which
comes from NHS surgical procedures."
*More information on the Green Surgery Challenge 2021 can be
found here - Green Surgery Challenge | Centre for Sustainable
Healthcare
For further information please contact:
Surgical Innovations Group plc www sigroupplc com
David Marsh, CEO Tel: 0113 230 7597
Charmaine Day, Co Sec & GFC
N+1 Singer (Nominated Adviser & Tel: 020 7496 3000
Broker)
Aubrey Powell / Rachel Hayes/ Iqra
Amin
Walbrook PR (Financial PR & Investor Tel: 020 7933 8780 or si@walbrookpr.com
Relations)
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584 391 303
About Surgical Innovations Group plc
The Group specialises in the design, manufacture, sale and
distribution of innovative, high quality medical products,
primarily for use in minimally invasive surgery. Our product and
business development is guided and supported by a key group of
nationally and internationally renowned surgeons across the
spectrum of minimally invasive surgical activity.
We design and manufacture and source our branded port access
systems, surgical instruments and retraction devices which are sold
directly in the UK home market through our subsidiary, Elemental
Healthcare, and exported widely through a global network of trusted
distribution partners. Many of our products in this field are based
on a "resposable" concept, in which the products are part
re-usable, part disposable, offering a high quality and
environmentally responsible solution at a cost that is competitive
against fully disposable alternatives.
Elemental also has exclusive UK distribution for a select group
of specialist products employed in laparoscopy, bariatric and
metabolic surgery, hernia repair and breast reconstruction.
In addition, we design and develop medical devices for carefully
selected OEM partners, and have also collaborated with a major UK
industrial partner to provide precision engineering solutions to
complex problems outside the medical arena.
We aim for our brands to be recognised and respected by
healthcare professionals in all major geographical markets in which
we operate and provide by development, partnership or acquisition a
broad portfolio of cost effective, procedure specific surgical
instruments and implantable devices that offer reliable solutions
to genuine clinical needs in the operating theatre environment.
The Group currently employs approximately 100 people across two
sites in the UK. Product design, engineering and manufacturing are
carried out at the SI site in Yorkshire. Commercial activities
including marketing, UK distribution and international sales and
marketing are based at Elemental Healthcare in Berkshire.
Further information
Further details of the Group's businesses are available on the
following websites:
www.sigroupplc.com
www.surginno.com
www.elementalhealthcare.co.uk
To receive regular updates by email, please contact
si@walbrookpr.com .
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAMZGGZMRNGMZZ
(END) Dow Jones Newswires
February 09, 2021 02:00 ET (07:00 GMT)
Surgical Innovations (LSE:SUN)
Historical Stock Chart
From Apr 2024 to May 2024
Surgical Innovations (LSE:SUN)
Historical Stock Chart
From May 2023 to May 2024